FIGURE

Fig. 2

ID

ZDB-FIG-180327-2

Publication

Melong et al., 2017 - Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Enzalutamide inhibits testosterone-induced proliferation of xenografted LNCaP cells in vivo. (A) Representative brightfield and fluorescent images of casper embryos injected with CMTMR labeled LNCaP cells at 24 hpi (baseline) and 96 hpi (endpoint) without and with the addition of enzalutamide (5?�M) alone or with testosterone (125?nM). Scale bar?=?200 microns. (B) Quantification of fluorescently labeled XT LNCaP cells showed that the addition of 5?�M of enzalutamide (ENZ) significantly decreased cell proliferation caused by the addition of 125?nM of testosterone (T) in the zebrafish model. Error Bars?=?Mean?�?SEM (N?=?4); *P?<?0.05, **P?<?0.01 for significant differences in cell numbers determined using the Student?s t-test. Groups of 20 embryos were sacrificed per replicate.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.